Safety and Cost-Effectiveness of Early Maternal Newborn Infant Discharge
NCT ID: NCT02372266
Last Updated: 2015-02-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2223 participants
INTERVENTIONAL
1997-04-30
2001-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Early Versus Very Early Postnatal Discharge on Hospital Readmissions in Newborns
NCT04422041
Effects of an Information-Based Discharge Service on Preterm Infants, Parents, and Hospitals
NCT06613386
Improving Parental Knowledge: Supplementation of Prematurity Counseling With Written Information
NCT01418950
Mother's Recorded Voice for Preterm Infants
NCT04559620
Hospitalizations in Neonatal Period and Early Discharge of Maternity
NCT05550272
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early Discharge Group
If safety criteria were met, women and infants were discharged home from the hospital at 12 to 24 hours after delivery with a planned home health visit within 48 hours of the discharge.
Early Maternal-Newborn Infant Discharge
Discharge from the hospital between 12-24 hours of life
Routine Stay Group
Women and newborns were discharged no sooner than 48 hours after delivery and could stay voluntarily up to 72 hours.
Routine discharge
Discharge of the mother and newborn 2 to 3 days after delivery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early Maternal-Newborn Infant Discharge
Discharge from the hospital between 12-24 hours of life
Routine discharge
Discharge of the mother and newborn 2 to 3 days after delivery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Multiple gestations
* Pre-existing maternal diabetes
* Maternal chronic hypertension
* Maternal age \< 18
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
59th Medical Wing
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
William H. Barth, Jr., M.D., Col(ret), USAF, MC
Chairman, Department of Obstetrics and Gynecology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William H Barth, MD
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DI950076
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
FWH19960042H
Identifier Type: OTHER
Identifier Source: secondary_id
SGO 96-042
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.